“…3-[4-[[[2-(9 H -Carbazol-9-yl)ethyl]amino]methyl]phenyl]-N-hydroxy-(2 E )-2-propenamide 13b. Following Method B, 9 H -carbazole-9-ethanamine hydrobromide (919 mg, 3.16 mmol), 1.4 equiv of Et 3 N, 10 (500 mg, 2.63 mmol), and NaBH(OAc) 3 (1.4 equiv) were reacted in DCE to afford 555 mg (47%) of 3-[4-[[[2-(9 H -carbazol-9-yl)amino]methyl]phenyl]-(2 E )-2-propenoic acid methyl ester: 1 H NMR (DMSO -d 6 ) δ 2.90 (t, 6.6 Hz, 2H), 3.72 (s, 5H), 4.48 (t, 6.6 Hz, 2H), 6.59 (d, 15.8 Hz, 1H), 7.19 (t, 7.0 Hz, 2H), 7.29 (d, 8.3 Hz, 2H), 7.44 (t, 7.7 Hz, 2H), 7.62 (m, 5H), 8.14 (d 7.9, 2H); 13 C NMR (DMSO -d 6 ) δ 43.00, 47.54, 51.38, 52.73, 109.72, 117.47, 119.03, 120.59, 122.42, 125.97, 128.60, 128.71, 132.77, 140.55, 143.85, 144.84, 176.14; m / z 385 (MH + ). Following Method E, the ester (405 mg, 1.05 mmol) was converted to the hydroxamate which was purified by RPHPLC to afford 13b as the TFA salt which was neutralized and treated with 1 equiv of lactic acid to provide 13b as the lactate salt (190 mg, 40%): retention time System 3 = 16.82 min, retention time System 4 = 28.11 min; 1 H NMR (DMSO -d 6 ) δ 1.26 (d, 6.8 Hz, 3H lactate), 3.26 (br s, 2H), 4.04 (q, 6.8 Hz, 1H lactate), 4.12 (br s, 1H), 4.67 (m, 1H), 6.52 (d, 15.8 Hz, 1H), 7.23 (t, 7.35 Hz, 2H), 7.48 (m 5H), 7.62 (m 4H), 8.16 (d, 7.9 Hz, 2H); 13 C NMR (DMSO -d 6 ) δ 20.91 (lactate), 45.65, 51.02, 66.21 (lactate), 109.49, 119.56, 120.78, 122.72, 126.24, 128.02, 130.31, 135.30, 138.06, 140.27, 162.94, 176.86 (lactate); m / z 386 (MH + ); HRMS (MH + ) calcd for C 24 H 24 N 3 O 2 , 386.1892, found 386.1869; mp 169.5−185.4 °C; Anal.…”